Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2011

Magro CM, A Crowson N. Folliculotropic T-cell lymphocytosis as a distinct form of pilotropic T-cell dyscrasia. Am J Clin Pathol. 2011;135(2):221-9.

Feser J, Tyler J. Chromatin structure as a mediator of aging. FEBS Lett. 2011;585(13):2041-8.

Oo ML, Chang S-, Thangada S, Wu M-, Rezaul K, Blaho V, et al. Engagement of S1P₁-degradative mechanisms leads to vascular leak in mice. J Clin Invest. 2011;121(6):2290-300.

Koon HB, Fingleton B, Lee JY, Geyer JT, Cesarman E, Parise RA, et al. Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma. J Acquir Immune Defic Syndr. 2011;56(1):64-8.

Moscat J, Diaz-Meco MT. Feedback on fat: p62-mTORC1-autophagy connections. Cell. 2011;147(4):724-7.

Hannah J, Zhou P. Maximizing target protein ablation by integration of RNAi and protein knockout. Cell Res. 2011;21(7):1152-4.

Ross AE, Marchionni L, Phillips TM, Miller RM, Hurley PJ, Simons BW, et al. Molecular effects of genistein on male urethral development. J Urol. 2011;185(5):1894-8.

Sboner A, Mu XJ, Greenbaum D, Auerbach RK, Gerstein MB. The real cost of sequencing: higher than you think! Genome Biol. 2011;12(8):125.

Geyer JT, Deshpande V. IgG4-associated sialadenitis. Curr Opin Rheumatol. 2011;23(1):95-101.

Nardella C, Lunardi A, Fedele G, Clohessy JG, Alimonti A, Kozma SC, et al. Differential expression of S6K2 dictates tissue-specific requirement for S6K1 in mediating aberrant mTORC1 signaling and tumorigenesis. Cancer Res. 2011;71(10):3669-75.